Butler Hospital BRAIN Program – Providence, Rhode Island Ketamine Clinics

✓ Last verified: January 14, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: The only academic medical center-based Spravato program in Rhode Island — run through Butler Hospital’s BRAIN Program with Brown University faculty oversight and potential access to cutting-edge clinical trials for treatment-resistant depression.

HealingMaps Take: Butler Hospital’s BRAIN Program (Behavioral Research and Innovation Network) is Rhode Island’s gold-standard option for Spravato and broader interventional psychiatric care. As part of the Care New England health system and affiliated with Brown University’s Warren Alpert Medical School, the program benefits from academic-grade clinical rigor, research-informed protocols, and faculty psychiatrists with specialized training in treatment-resistant depression. For patients who want the highest level of clinical oversight for their Spravato treatment — particularly those with complex presentations including suicidal ideation or failed responses to multiple prior treatments — an academic setting is qualitatively different from private-practice alternatives. Butler’s eligibility criteria are clinically appropriate: non-bipolar major depressive disorder, failed multiple antidepressants, no recent substance use or significant neurological disorders. The academic affiliation also means patients may have access to emerging treatments and clinical trials not available elsewhere in New England. The Blackstone Boulevard campus is a historic psychiatric hospital setting that signals clinical seriousness. The primary limitation is that Butler is a formal medical program with referral-and-evaluation intake — less convenient than walk-in private clinics — but the trade-off is a level of clinical rigor unmatched in the Rhode Island market.

Market Position: Butler Hospital BRAIN Program is a Spravato-certified clinic in the Providence metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.

Ketamine Protocols Compared — What’s Offered at Butler Hospital BRAIN Program

Industry pricing reference. Butler Hospital BRAIN Program has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

What to Expect at Your First Butler Hospital BRAIN Program Appointment

1. Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (401) 455-6632 to schedule.
2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Butler Hospital BRAIN Program clinical team.
3. First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at 345 Blackstone Boulevard, Providence, RI 02906. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.

What to Ask on Your Butler Hospital BRAIN Program Consult Call

• How long has the Butler Hospital BRAIN Program clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
• How long does Butler Hospital BRAIN Program’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
• Does Butler Hospital BRAIN Program require a referral from a current treating psychiatrist, and how do you handle outside-prescriber medication-management coordination?
• What does Butler Hospital BRAIN Program recommend for patients who don’t respond to the standard 6-session acute series?

Providence Ketamine Market Snapshot

Sources: CDC PLACES 2023 (Providence County, RI, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.

• Adult depression in Providence County, RI: 23.1%
• Frequent mental distress (14+ days per month): 17.9%
• Adults lacking health insurance: 10.3%
• Providence County population: 657,984 · median household income $72,579
• Recent Providence-area inquiries to HealingMaps: A growing stream of Rhode Island residents have recently contacted us seeking ketamine care

Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.

From the 2026 Ketamine Industry Report

Depression is the #1 condition cited in 20.9% of HealingMaps ketamine inquiries, followed by PTSD (13.5%) and anxiety (11.4%) — the three together account for nearly half of all patient demand. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.

Patient Questions about Butler Hospital BRAIN Program

This 2-question summary is matched to the protocols and conditions Butler Hospital BRAIN Program treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

Does Butler Hospital BRAIN Program offer Spravato (esketamine)?

Yes — Butler Hospital BRAIN Program offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.

Is Butler Hospital BRAIN Program suited for treatment-resistant depression?

Butler Hospital BRAIN Program treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Location